XenoFarma successfully participated in a scientific symposium titled “Modern Treatment of Allergic and Non-Allergic Rhinitis: Phytotherapy and Hypertonic Solutions,” held on December 15, 2025, at the White Tower Hotel in Mosul.
The symposium featured a comprehensive scientific lecture that provided an up-to-date overview of contemporary therapeutic strategies for the management of allergic and non-allergic rhinitis. The session addressed current clinical challenges and emphasized the importance of evidence-based, patient-centered treatment approaches.
XenoFarma was officially represented by Dr. Sofian M. Sulaiman, Marketing Manager, who delivered a focused scientific presentation highlighting an innovative approach to rhinitis management through the use of Allerdep® and Influprop® nasal sprays. The presentation detailed the pharmacological properties, mechanisms of action, and clinical applications of both products in alleviating nasal inflammation and improving patient quality of life.
In addition to clinical efficacy, the discussion addressed pricing and cost-effectiveness, including a comparative overview of Erbozeta products’ pricing inside Iraq versus international markets, emphasizing accessibility and value for patients and healthcare providers.
Overall, the symposium represented a valuable scientific and promotional initiative for XenoFarma, enhancing product visibility, strengthening clinical confidence, and fostering productive professional relationships with healthcare specialists in the region.
Event Date: December 15, 2025
Start Time: 8:30 PM
Venue: White Tower Hotel
City: Mosul, Iraq
